Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page previously showing a 403 Forbidden error now loads the full study record for NCT03447678, including the study overview, eligibility criteria, and locations. Additional metadata sections such as IPD sharing plans and relevant MeSH terms were added to enhance contextual information and searchability.SummaryDifference70%

- Check19 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. Access to the study details is blocked, and the usual information is replaced by an error screen.SummaryDifference21%

- Check40 days agoChange DetectedThe page footer shows a new revision label: v3.6.6 replaced v3.6.5. This reflects a minor template or system update that does not alter the study details or documented content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page. This indicates a newer version of the page has been published.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the study record. This metadata change does not alter the study data, endpoints, or eligibility criteria.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a new page release or patch. It represents a version change rather than a substantive change to the content.SummaryDifference0.0%

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.